MedPath

Pioneer Surgical Technology, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Acellular Dermal Matrix Investigation in Breast Reconstruction

Not Applicable
Recruiting
Conditions
Breast Reconstruction
Interventions
Device: Acellular Dermal Matrix (Cortiva Tissue Matrix)
First Posted Date
2024-06-13
Last Posted Date
2025-04-03
Lead Sponsor
RTI Surgical
Target Recruit Count
467
Registration Number
NCT06456554
Locations
🇺🇸

University of Colorado, Aurora, Colorado, United States

🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

🇺🇸

Washington University, Saint Louis, Missouri, United States

and more 3 locations

A Prospective Study of Fortiva in Hernia Repair

Conditions
Ventral Hernia
Abdominal Wall Reconstruction
Incisional Hernia
Interventions
Device: Fortiva Tissue Matrix
First Posted Date
2023-10-26
Last Posted Date
2024-04-09
Lead Sponsor
RTI Surgical
Target Recruit Count
120
Registration Number
NCT06101979
Locations
🇬🇧

James Paget University Hospital, Great Yarmouth, United Kingdom

Streamline Occipito-Cervico-Thoracic System Post-Market Clinical Follow-up

Completed
Conditions
Spinal Stenosis Occipito-Atlanto-Axial
Spinal Stenosis Cervical
Spinal Stenosis Cervicothoracic Region
Spinal Disease
Spinal Instability
First Posted Date
2019-11-21
Last Posted Date
2020-10-27
Lead Sponsor
RTI Surgical
Target Recruit Count
60
Registration Number
NCT04171544
Locations
🇺🇸

Las Vegas Neurosurgical Institute, Las Vegas, Nevada, United States

🇺🇸

Spine Nevada, Reno, Nevada, United States

A Post Market Prospective Study of FORTIVA® 1mm Porcine Dermis

Not Applicable
Completed
Conditions
Mammoplasty
Interventions
Device: Fortiva® 1mm
First Posted Date
2018-11-16
Last Posted Date
2024-05-02
Lead Sponsor
RTI Surgical
Target Recruit Count
87
Registration Number
NCT03744013
Locations
🇬🇧

Nightingale Breast Unit, Manchester University NHS Foundation Trust (MFT), Wythenshawe Hospital, Manchester, United Kingdom

🇩🇪

Frankfurt University Hospital, Frankfurt am Main, Germany

🇩🇪

University Hospital Technical University, Munich, München, Germany

and more 3 locations

Evaluation of the Fortilink IBF System With TETRAfuse Technology

Completed
Conditions
Cervical and Lumbar Fusion
First Posted Date
2018-10-09
Last Posted Date
2019-10-02
Lead Sponsor
RTI Surgical
Target Recruit Count
119
Registration Number
NCT03699891
Locations
🇺🇸

Spine Institute of South Florida, Delray Beach, Florida, United States

🇺🇸

Rocky Mountain Spine, Lone Tree, Colorado, United States

🇺🇸

Los Angeles Orthopedic Institute, Sherman Oaks, California, United States

and more 2 locations

Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion

Not Applicable
Completed
Conditions
Spondylosis
Degenerative Disc Disease
Spondylolisthesis
Interventions
Other: map3® Cellular Allogeneic Bone Graft
First Posted Date
2015-12-11
Last Posted Date
2021-05-24
Lead Sponsor
RTI Surgical
Target Recruit Count
30
Registration Number
NCT02628210
Locations
🇺🇸

Spine Surgery of Buffalo Niagara, LLC, Niagara Falls, New York, United States

🇺🇸

AXIS Neurosurgery and Spine of WNY, PLLC, Williamsville, New York, United States

🇺🇸

Carl & Edyth Lindner Center for Research The Christ Hospital, Cincinnati, Ohio, United States

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

Not Applicable
Completed
Conditions
Ventral Hernia
Interventions
Device: Fortiva™ Porcine Dermis
Device: Strattice™ Reconstructive Tissue Matrix
First Posted Date
2015-10-27
Last Posted Date
2024-12-27
Lead Sponsor
RTI Surgical
Target Recruit Count
120
Registration Number
NCT02587403
Locations
🇺🇸

Washington University, Saint Louis, Missouri, United States

Comparison of nanOss Cervical IBF System to C-Plus PEEK IBF Device With Autograft

Not Applicable
Completed
Conditions
Intervertebral Disc Degeneration
Interventions
Device: nanOss
Device: C-Plus
First Posted Date
2015-10-26
Last Posted Date
2020-07-27
Lead Sponsor
RTI Surgical
Target Recruit Count
11
Registration Number
NCT02586116
Locations
🇧🇪

Ziekenhuis Oost Limburg, Genk, Belgium

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

Phase 4
Terminated
Conditions
Deformity of Bone
Foot Deformities, Acquired
Fracture of Foot
Disorder of Joint of Foot
Interventions
Device: map3
First Posted Date
2014-06-11
Last Posted Date
2015-04-01
Lead Sponsor
RTI Surgical
Target Recruit Count
1
Registration Number
NCT02161016
Locations
🇺🇸

Saint Francis Hospital, Roslyn, New York, United States

NanOss Bioactive With Autograft and Bone Marrow Aspirate in the Posterolateral Spine

Not Applicable
Withdrawn
Conditions
Lumbar Spinal Stenosis Secondary to Other Disease
Interventions
Device: Autograft
Device: nanOSS
First Posted Date
2013-12-09
Last Posted Date
2017-01-04
Lead Sponsor
Pioneer Surgical Technology, Inc.
Registration Number
NCT02005341
© Copyright 2025. All Rights Reserved by MedPath